相关实验视频

Updated: Jul 8, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

用伊涅比利祖马布治疗血清阴性神经炎光学谱系障碍:一个病例报告

Dominik Lehrieder¹, Nikolaos Zapantis¹, Mirko Pham²

¹Department of Neurology, University Hospital Würzburg, Würzburg, Germany.

Frontiers in neurology

|December 11, 2023

概括

血清阴性神经髓炎光学谱障碍 (NMOSD) 可能是攻击性的. 作为一种B细胞消耗疗法,inebilizumab在抗体缺失时显示出治疗这种具有挑战性的疾病的前景.

科学领域:

神经免疫学神经免疫学
神经学神经学

背景情况:

神经脊髓炎光学谱系障碍 (NMOSD) 是一种严重的自身免疫性中枢神经系统炎症状况.
血清阴性NMOSD缺乏特定的水素4 (AQP4) 抗体,使诊断和治疗复杂化.
对AQP4抗体阳性NMOSD的治疗领域已取得显著进展.

研究的目的:

介绍一例在患有侵袭性阴性血清性NMOSD的患者中成功治疗伊内比利祖马布的病例.
为了突出潜在的治疗选择为血清阴性NMOSD.

主要方法:

一个56岁的女性患者的病例报告,患有血清阴性NMOSD.
进行的治疗是inebilizumab.

主要成果:

这位患者出现了双侧视神经炎和纵向扩展性髓炎.
通过inebilizumab观察到成功的治疗结果.

结论:

伊内比利祖马布可能是积极的阴性血清性NMOSD的可行的治疗选择.
需要进一步的研究来比较CD19导向的B细胞枯竭与Rituximab用于NMOSD治疗.

关键词:

在 AQP4 AQP4 中.CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 CD19 这是NMOSD的NMOSD.案例报告案例报告不可能的Inebilizumab.纵向扩展的横向骨髓炎视神经炎是一种视神经炎.血清阴性血清阴性

更多相关视频

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Bioluminescence and Near-infrared Imaging of Optic Neuritis and Brain Inflammation in the EAE Model of Multiple Sclerosis in Mice

Published on: March 1, 2017

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

Published on: April 5, 2019

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...